{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:30:53Z","timestamp":1794324653971,"version":"4.9.0"},"reference-count":0,"publisher":"ScopeMed","issue":"5","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":155,"URL":"https:\/\/www.openveterinaryjournal.com\/?sec=licenseinfo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Vet J"],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:p>Background: \nThe intramuscular (IM) administration of 7.5\u201310 mg\/kg of alfaxalone produces anesthetic effects that enabled endotracheal intubation with mild cardiorespiratory depression in dogs. However, the effects of IM co-administration of medetomidine, butorphanol, and alfaxalone on cardiorespiratory function under inhalation anesthesia have not been studied.\nAim: \nTo assess the cardiorespiratory function following the IM co-administration of 5 \u03bcg\/kg of medetomidine, 0.3 mg\/kg of butorphanol, and 2.5 mg\/kg of alfaxalone (MBA) in dogs anesthetized with sevoflurane. \nMethods: \nSeven intact healthy Beagles (three males and four females, aged 3\u20136 years old and weighing 10.0\u201318.1 kg) anesthetized with a predetermined minimum alveolar concentration (MAC) of sevoflurane were included in this study. The baseline cardiorespiratory variable values were recorded using the thermodilution method with a pulmonary artery catheter after stabilization for 15 min at 1.3 times their individual sevoflurane MAC. The cardiorespiratory variables were measured again following the IM administration of MBA. Data are expressed as median [interquartile range] and compared with the corresponding baseline values using the Friedman test and Sheff\u2019s method. A P &lt; 0.05 was considered statistically significant. \nResults: \nThe intramuscular administration of MBA transiently decreased the cardiac index (baseline: 3.46 [3.18\u20133.69], 5 min: 1.67 [1.57\u20131.75] L\/min\/m2 : P &lt; 0.001), respiratory frequency, and arterial pH. In contrast, it increased the systemic vascular resistance index (baseline: 5,367 [3,589\u20136,617], 5 min:10,197 [9,955\u201315,005] dynes sec\/cm5\/m2 : P = 0.0092), mean pulmonary arterial pressure, and arterial partial pressure of carbon dioxide. \nConclusion: \nThe intramuscular administration of MBA in dogs anesthetized with sevoflurane transiently decreased cardiac output due to vasoconstriction. Although spontaneous breathing was maintained, MBA administration resulted in respiratory acidosis due to hypoventilation. Thus, it is important to administer MBA with caution to dogs with insufficient cardiovascular function. In addition, ventilatory support is recommended.<\/jats:p>","DOI":"10.5455\/ovj.2024.v14.i5.20","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T04:03:00Z","timestamp":1717473780000},"page":"1251","source":"Crossref","is-referenced-by-count":1,"title":["Cardiorespiratory effects of intramuscular alfaxalone combined with low-dose medetomidine and butorphanol in dogs anesthetized with sevoflurane"],"prefix":"10.5455","volume":"14","author":[{"given":"Keiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3407","container-title":["Open Veterinary Journal"],"original-title":[],"link":[{"URL":"https:\/\/ejmanager.com\/mnstemps\/100\/100-1689921102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:17:00Z","timestamp":1791483420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejmanager.com\/mnstemps\/100\/100-1689921102.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5455\/ovj.2024.v14.i5.20","relation":{},"ISSN":["2226-4485"],"issn-type":[{"value":"2226-4485","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}